4.7 Article

Prospective Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Tumor Staging in Biliary Tract Cancers

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG

Lianjun Lan et al.

Summary: The study aimed to compare the detection performance of [(68) Ga]Ga-DOTA-FAPI-04 and [F-18]FDG PET/CT in patients with various oncological and non-oncological lesions. [(68) Ga]Ga-DOTA-FAPI-04 PET/CT showed significantly higher uptake and detection rate for primary, nodal, and distant metastatic lesions of solid tumors compared to [F-18]FDG PET/CT. Except for myeloma and lymphoma, [(68) Ga]Ga-DOTA-FAPI-04 PET/CT demonstrated superior detection efficacy for various primary and metastatic lesions than [F-18]FDG PET/CT.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings

Haojun Chen et al.

Summary: This prospective study evaluated the potential usefulness of [Ga-68]Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) in oncological evaluation of patients with inconclusive [F-18]FDG PET/CT findings. The study found that [Ga-68]Ga-DOTA-FAPI-04 may have a complementary role in discriminating mass lesions on conventional imaging, locating unknown primary sites in biopsy-proven metastatic malignancy, modifying tumor staging, and detecting suspected disease recurrence. However, caution should be exercised when interpreting [Ga-68]Ga-DOTA-FAPI-04 PET/CT images in tumors complicated with inflammation.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study

Ximin Shi et al.

Summary: This study compared the performance of Ga-68-labelled fibroblast activating protein inhibitor (FAPI) PET and F-18-FDG PET for imaging of hepatic tumours, finding that Ga-68-FAPI PET-CT has superior potential in the detection of primary hepatic malignancy compared to F-18-FDG.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

Manuel Roehrich et al.

Summary: The use of Ga-68-FAPI PET/CT imaging in PDAC patients led to significant changes in TNM staging and impacted the management of some patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI-46 PET/MR Detects Recurrent Cholangiocarcinoma and Intraductal Papillary Mucinous Neoplasm in a Patient Showing Increasing CEA with Negative 18F-FDG PET/CT and Conventional CT

Dheeratama Siripongsatian et al.

Summary: (68)Ga-FAPI-46 PET imaging showed significantly higher tumor contrast in recurrent intrahepatic cholangiocarcinoma and nodal metastasis, which were undetectable by FDG PET or conventional CT scan. This finding altered patient management and highlighted the importance of validation and larger studies.

NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT

Liang Zhao et al.

Summary: This study aimed to explore the efficacy of [Ga-68]Ga-DOTA-FAPI-04 PET/CT compared to F-18-FDG PET/CT in evaluating peritoneal carcinomatosis in cancer patients. The results showed that [Ga-68]Ga-DOTA-FAPI-04 PET/CT had higher sensitivity, particularly in patients with gastric cancer, and provided better detection of peritoneal lesions compared to F-18-FDG PET/CT.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of( 68)Ga-FAPI and F-18-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers

Yizhen Pang et al.

Summary: This study compared the diagnostic efficacy of Ga-68-FAPI PET/CT and F-18-FDG PET/CT in gastrointestinal malignancies, showing that Ga-68-FAPI PET/CT outperformed in detecting primary and metastatic lesions, with higher sensitivity.

RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Frederik L. Giesel et al.

Summary: The study aimed to compare Ga-68-FAPI and F-18-FDG in organ biodistribution and tumor uptake in PET/CT, showing that Ga-68-FAPI has lower uptake in most normal tissues compared to F-18-FDG, resulting in significantly higher TBRs at some sites for Ga-68-FAPI.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Katharina Dendl et al.

Summary: Ga-68-FAPI-PET/CT demonstrates high tracer uptake for staging and follow-up of gynecological tumors, with sharp contrasts in primary and metastatic lesions and higher TBRs than F-18-FDG-PET/CT. The presence or absence of the menstrual cycle seems to correlate with FAPI accumulation in the normal endometrium and breast.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Medical Laboratory Technology

Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma

Sun-Young Jun et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Haojun Chen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers

Frederik L. Giesel et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

Clemens Kratochwil et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic accuracy of 18F-FDGPET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis

Seong-Jang Kim et al.

BRITISH JOURNAL OF RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts

Anastasia Loktev et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Review Oncology

Cholangiocarcinoma

Michela Squadroni et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Review Radiology, Nuclear Medicine & Medical Imaging

PET or PET/CT for Detection of Peritoneal Carcinomatosis A Meta-Analysis

Ming-Che Chang et al.

CLINICAL NUCLEAR MEDICINE (2013)

Article Oncology

Diagnostic Value of FDG-PET for Lymph Node Metastasis and Outcome of Surgery for Biliary Cancer

Shogo Kobayashi et al.

JOURNAL OF SURGICAL ONCOLOGY (2011)

Review Gastroenterology & Hepatology

Clinical diagnosis and staging of cholangiocarcinoma

Boris Blechacz et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET in the diagnosis of hilar cholangiocarcinoma

A Fritscher-Ravens et al.

NUCLEAR MEDICINE COMMUNICATIONS (2001)